Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. [electronic resource] by
- Wightman, S C
- Uppal, A
- Pitroda, S P
- Ganai, S
- Burnette, B
- Stack, M
- Oshima, G
- Khan, S
- Huang, X
- Posner, M C
- Weichselbaum, R R
- Khodarev, N N
Producer: 20150930
In:
British journal of cancer vol. 113
Availability: No items available.
|
|
20.
|
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor. [electronic resource] by
- Voce, D J
- Schmitt, A M
- Uppal, A
- McNerney, M E
- Bernal, G M
- Cahill, K E
- Wahlstrom, J S
- Nassiri, A
- Yu, X
- Crawley, C D
- White, K P
- Onel, K
- Weichselbaum, R R
- Yamini, B
Producer: 20150827
In:
Oncogene vol. 34
Availability: No items available.
|